APHRODITE
ActiveSummary
APHRODITE has been active since 1994 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €6,540 and a net result of €1,090. Equity is shrinking by about 20% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 36% of 16,658 sector peers (NACE 56, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
09-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Back to profitnet €822
Net result €822 after 3 loss-making years.
24-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Weakest financial yearnet -€15,907
Net result drops to -€15,907, the lowest in the series; recovery starts the following year.
26-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
10-08
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format · 10 days late
2021
30-06
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
31-12
Financial
Back to profitnet €4,015
Net result €4,015 after 2 loss-making years.
22-09
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format · 53 days late
2019
21-06
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
2018
28-06
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2017
12-07
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 32 annual accounts filed, the latest 10 are here; all 32 are under Financials.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.